Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 348)
Posted On: 09/25/2025 1:36:49 PM
Post# of 157259
Posted By: cardamine
Re: MGK_2 #157221
thanks mgk...I'm not clear on what relates to what in the chart--I was looking specifically at the 1 year survival rate mentioned in the Pestell study and trying to see how it compared to trodelvy or keytruda (SOC) alone:

Survival outcomes:
Of the patients (median age, 48.5 years (32-83; N=28), prior lines of therapy in the metastatic setting (median=2), visceral metastases (64% (N=18)), of which (N=8) had brain metastases, and non-visceral metastases (36% (N=10)), ∼18% of heavily pretreated mTNBC patients are currently alive after median >60 months. (1 year survival 35.7%; 2 year survival 21.4%; 3 and 4 year survival 17.9%).

So from your chart,
Median Overall Survival (OS)
(Keytruda) 23.0 months (PD-L1 CPS ≥10) vs. 16.1 months (chemo alone)
(Trodelvy) 11.8 months vs. 6.9 months (chemo alone)

What number is the apples-to-apples comparison to the 23.0 and 11.8 -- is there a pure Median OS in Pestell's abstract? Is it the >60 months?? That would be astounding but I want to make sure they're the same parameters. That's why I latched onto the 1 year survival rate, to try to find a straightforward point of comparison.

(I apologize for my blurryheadedness-- I took stats in grad school, even got an A, but that was decades ago and not in medicine!)













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site